The Trophoblast as an Active Regulator of the Pregnancy Environment in Health and Disease: An Emerging Concept

Advances in Organ Biology

Volumn 1, Issue C, 1996, Pages 121-152

  Morrish, Donald W ^a   Dakour, Jamal ^a   Li, Hongshi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956837924     PISSN: 15692590     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2590(08)60070-1     Document Type: Chapter

References (171)

1. Altman D.J., Schneider S.L., Thompson D.A., Cheng H.-L., and Tomasi T.B. A transforming growth factor β2(TGF-β2)-like immunosuppressive factor in amniotic fluid and localization of TGFβ2 MRNA in the pregnant uterus. J. Exp. Med. 172 (1990) 1391-1401
2. Aschheim S., and Zondek B. Anterior pituitary hormone and ovarian hormone in the urine of pregnant women [Hypophysenvorderlappenhormon und ovarial hormon im Harn von Schwangeren]. Klin. Wochenschr. 6 (1927) 1322
3. Autio-Harmainen H., Hurskainen T., Niskasaari K., Hoyhtya M., and Tryggvason K. Simultaneous expression of 70 kilodalton type IV collagenase and type IV collagen al (IV) chain genes by cells of early human placenta and gestational endometrium. Lab. Invest. 67 (1992) 191-200
4. Autio-Harmainen H., Sandberg M., Pihlajaniemi T., and Vuorio E. Synthesis of laminin and type IV collagen by trophoblastic cells and fibroblastic stromal cells in the early human placenta. Lab. Invest. 64 (1991) 483-491
5. Baird A. Editorial: Fibroblast growth factors: What's in a name?. Endocrinology 132 (1993) 487-488
6. Behrendtsen O., Alexander C.M., and Werb Z. Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. Development 114 (1992) 447-456
7. 2 inhibits production of Thl lymphokines but not of Th2 lymphokines. J. Immunol. 146 (1991) 108-113
8. Bobik A., Grooms A., Millar J.A., Mitchell A., and Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle. Am. J. Physiol. 258 (1990) C408-C415
9. Bonin P.D., Leadley R.J., and Erickson L.A. Growth factor-induced modulation of endothelin-1 binding to human smooth-muscle cells. J. Cardiovasc. Pharmacol. 23 8 (1993) S125-S127
10. Boura A.L.A., and Walters W.A.W. Autacoids and the control of vascular tone in the human umbilical-placental circulation. Placenta 12 (1991) 453-477
11. Brennecke S.P., Dilulio J.L., Gude N.M., and King R.G. Nitric oxide synthase activity of preterm human placental tissue is reduced in pre-eclampsia. Placenta 15 (1994) A6
12. Brenner C.A., Adler R.R., Rappolee D.A., Pedersen R.A., and Werb Z. Genes for extracellular matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development. Genes Develop. 3 (1989) 848-859
13. Bulmer J.N., Morrison L., Johnson P.M., and Meager A. Immunohistochemical localization of interferons in human placental tissues in normal, ectopic, and molar pregnancy. J. Reprod. Immunol. 22 (1990) 109-116
14. Buttery L.D.K., McCarthy A., Springall D.R., Sullivan M.H.F., Elder M.G., Michel T., and Polak J.M. Endothelial nitric oxide synthase in the human placenta: Regional distribution and proposed regulatory role at the feto-maternal interface. Placenta 15 (1994) 257-265
15. Cai W.Q., Terenghi G., Bodin P., Burnstock G., and Polak J.M. In situ hybridization of atrial natriuretic peptide mRNA in the endothelial cells of human umbilical vessels. Histochemistry 100 (1993) 277-283
16. Casey M.L., and MacDonald P.C. Cytokines in the human placenta, fetal membranes, uterine decidua, and amniotic fluid. In: Rice G.E., and Brennecke S.P. (Eds). Molecular Aspects of Placental and Fetal Autacoids (1993), CRC Press, Boca Raton, FL 361-394
17. Cattini P.A., Nickel B., Bock M., and Kardami E. Immunolocalization of basic fibroblast growth factor (bFGF) in growing and growth-inhibited placental cells: A possible role for bFGF in placental cell development. Placenta 12 (1991) 341-352
18. Cedard L., Alsat E., Urtasun M.-J., and Varangot J. Studies on the mode of action of luteinizing hormone and chorionic gonadotropin on estrogenic biosynthesis and glycogenosis by human placenta perfused in vitro. Steroids 16 (1970) 361-375
19. 1α from cultured human trophoblast cells. Placenta 15 (1994) A9
20. Chen E.Y., Liao Y.-C., Smith D.H., Barrera-Saldana H.A., Gelinas R.E., and Seeburg P.H. The human growth hormone locus: Nucleotide sequence, biology, and evolution. Genomics 4 (1989) 479-497
21. Chen H.-L., Yang Y., Hu X.-L., Yelavarthi K.K., Fishback J.L., and Hunt J.S. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am. J. Reprod. Immunol. 139 (1991) 327-335
22. Chibbar R., Miller F.D., and Mitchell B.F. Synthesis of oxytocin in amnion, chorion, and decidua may influence the timing of human parturition. J. Clin. Invest. 91 (1993) 185-192
23. Chibbar R., Wong S., Miller F.D., and Mitchell B.F. Estrogen stimulates oxytocin gene expression in human chorio-decidua. J. Clin. Endocrinol. Metab. 80 (1995) 567-572
24. Clark D.A., Flanders K.C., Banwatt D., Millar-Book W., Manuel J., Stedronska-Clark J., and Rowley B. Murine pregnancy decidua produces a unique immunosuppressive molecule related to transforming growth factor β-2. J. Immunol. 144 (1990) 3008-3014
25. Clifton V.L., Read M.A., Leitch I.M., Boura A.L.A., Robinson P.J., and Smith R. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation. J. Clin. Endocrinol. Metab. 79 (1994) 666-669
26. Cross J.C., Werb Z., and Fisher S.J. Implantation and the placenta: Key pieces of the development puzzle. Science 266 (1994) 1508-1518
27. Cuevas P., Carceller E., Ortega S., Zazo M., Nieto I., and Gimenez-Gallego G. Hypotensive activity of fibroblast growth factor. Science 254 (1991) 1208-1210
28. Daiter E., Pampfer S., Yeung Y.G., Barad D., Stanley E.R., and Pollard J.W. Expression of colony-stimulating factor-1 in the human uterus and placenta. J. Clin. Endocrinol. Metab. 74 (1992) 850-858
29. Damsky C.H., Fitzgerald M.L., and Fisher S.J. Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J. Clin. Invest. 89 (1992) 210-222
30. Edwin S.S., and Mitchell M.D. Arachidonic acid metabolism via lipoxygenase pathways in the placenta and fetal membranes. In: Rice G.E., and Brennecke S.P. (Eds). Molecular Aspects of Placental and Fetal Membrane Autacoids (1993), CRC Press, Boca Raton, FL 127-156
31. Ellis S. HLA-G: At the interface. Am. J. Reprod. Immunol. 23 (1990) 84-86
32. Emonard H., Christiane Y., Smet M., Grimaud J.A., and Foidart J.M. Type IV and interstitial collagenolytic activities in normal and malignant trophoblast cells are specifically regulated by the extracellular matrix. Invasion Metast. 10 (1990) 170-177
33. Estelles A., Keeton J.G.M., Eguchi Y., Aznar J., Grancha S., Espana R., Loskutoff D.J., and Schleef R.R. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood 84 (1994) 143-150
34. Falcone T., and Little A.B. Maintenance of pregnancy and the initiation of normal labor. In: Tulchinsky D., and Little A.B. (Eds). Maternal-Fetal Endocrinology (1994), W. B. Saunders Co., Philadelphia 351-363
35. Feinberg R.F., Kao L.-C., Haimowitz J.E., Queenan J.T., Wun T.-C., Strauss J.F., and Kliman H.J. Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. Lab. Invest. 61 (1989) 20-26
36. Feinberg R.F., Kliman H.J., and Lockwood C.J. Is oncofetal fibronectin a trophoblast glue for human implantation? Am. J. Pathol. 138 (1991) 537-543
37. Fernandez P.L., Merino M.J., Nogales F.F., Charonis A.S., Stetler-Stevenson W., and Liotta L. Immunohistochemical profile of basement membrane proteins and 72 kilodalton type IV collagenase in the implantation placental site. Lab. Invest. 66 (1992) 572-579
38. Ferry B.L., Sargent I.L., Starkey P.M., and Redman C.W.G. Cytotoxic activity against trophoblast and choriocarcinoma cells of large granular lymphocytes from human early pregnancy decidua. Cell. Immunol. 132 (1991) 140-149
39. Fisher S.J., Leitch M.S., Kantor M.S., Basbaum C.B., and Kramer R.H. Degradation of extracellular matrix by the trophoblastic cells of first-trimester human placentas. J. Cell. Biochem. 27 (1985) 31-41
40. Fisher S.J., Cui T.-Y., Zhang L., Hartman L., Grahl K., Zhang G.-Y., Tarpey J., and Damsky C.H. Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J. Cell Biol. 109 (1989) 891-902
41. Flaumenhaf R., Abe M., Mignatti P., and Rifkin D.B. Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: Regulation of plasminogen activator activity. J. Cell Biol. 118 (1992) 901-909
42. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1 (1995) 27-31
43. Frankenne F., Rentier-Delrue E., Scippo M.-L., Martial J., and Hennen G. Expression of the growth hormone variant gene in human placenta. J. Clin. Endocrinol. Metab. 64 (1987) 635-637
44. Garcia-Lloret M., Morrish D.W., Wegmann T.G., Honore L., Turner A.R., and Guilbert L.J. Demonstration of functional cytokine-placental interactions: CSF-1 and GM-CSF stimulate human cytotrophoblast differentiation and peptide hormone secretion. Exp. Cell Res. 214 (1994) 46-54
45. Garfield R.E., Rabideau S., Challis J.R.G., and Daniel E.E. Hormonal control of gap junctions in sheep myometrium. Biol. Reprod. 21 (1979) 999-1007
46. Gibbs R.S., Romero R., Hillier S.L., Eschenbach D.A., and Sweet R.L. Areview of premature birth and subclinical infection. Am. J. Obstet. Gynecol. 166 (1992) 1515-1528
47. Glasser S.R., Julian J.A., Decker G.L., Tang J.-Y., and Carson D.D. Development of morphological and functional polarity in primary cultures of immature rat uterine epithelial cells. J. Cell Biol. 107 (1988) 2409-2423
48. Goldyne M.E., and Stobo J.D. Immunoregulatory role of prostaglandins and related lipids. Crit. Rev. Immunol. 2 (1981) 189-224
49. Goodfellow C.F., and Taylor P.V. Extraction and identification of trophoblast cells circulating in peripheral blood during pregnancy. Br. J. Obstet. Gynecol. 89 (1982) 65-68
50. Gospodarowicz D., Cheng J., Lui G.-M., Fujii D.K., Baird A., and Bohlen P. Fibroblast growth factor in the human placenta. Biochem. Biophys. Res. Commun. 128 (1985) 554-562
51. Gossrau R., Graf R., Ruhnke M., and Hanski C. Proteases in the human full-term placenta. Histochemistry 86 (1987) 405-413
52. Graham C.H., and Lala P.K. Mechanisms of placental invasion of the uterus and their control. Biochem. Cell Biol. 70 (1992) 867-874
53. Grainger D.J., Kemp P.R., Metcalf J.C., Liu A.C., Lawn R.M., Williams N.R., Grace A.A., Schofield P.M., and Chauhan A. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nature Med. 1 (1995) 74-79
54. Gris J.-C., Neveu S., Mares P., Biron C., Hedon B., and Schved J.-F. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. J. Lab. Clin. Med. 122 (1993) 606-615
55. Halban J. The internal secretions of the ovaries and placenta and their importance for the function of the mammary glands in pregnancy [Die innere Secretion von Ovarium und Placenta und ihre Bedeutung fur die Function der Milchdruse]. Archiv fur Gynakologie. 75 (1905) 353-411
56. Harper M.J.K., Khodr G.S., and Valenzuela G. Prostaglandin production by human term placentas in vitro. Prostaglandins Leukotrienes and Medicine 11 (1983) 121-129
57. Harris S.J., Anthony F.W., Jones D.B., and Masson G.M. Pregnancy-specific-β1 -glycoprotein: Effect on lymphocyte proliferation in vitro. J. Reprod. Immunol. 6 (1984) 267-270
58. Hennen G., Frankenne F., Closset J., Gomez F., Pirens G., and El Khayat N. A human placental GH: Increasing levels during second half of pregnancy with pituitary GH suppression as revealed by monoclonal antibody radioimmunoassays. Int. J. Fertil. 30 (1985) 27-33
59. Hertig A.T., and Rock J. Two human ova of the pre-villous stage, having a developmental age of about seven and nine days respectively. Contrib. Embryol. 31 (1945) 67-86
60. Herz J., Clouthier D.E., and Hammer R.E. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 71 (1992) 411-421
61. Hill D.J. What is the role of growth hormone and related peptides in implantation and the development of the embryo and fetus. Horm. Res. 38 1 (1992) 28-34
62. Hill J.A. Sporadic and recurrent spontaneous abortion. Curr. Probl. Obstet. Gynecol. Fertil. 17 (1994) 113-164
63. Hofmann G.E., Glatstein I., Schatz E., Heller D., and Deligdisch L. Immuno-histochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites. Am. J. Obstet. Gynecol. 170 (1994) 671-676
64. Hoshina M., Boothby M., and Boime I. Cytological localization of chorionic gonadotropin a and placental lactogen mRNA during development of the human placenta. J. Cell Biol. 93 (1982) 190-198
65. Hoshina M., Hussa R., Pattillo R., and Boime I. Cytological distribution of chorionic gonadotropin subunit and placental lactogen messenger RNA in neoplasms derived from human placenta. J. Cell Biol. 97 (1983) 1200-1206
66. Huhtaniemi I.T., Korenbrot C.C., and Jaffee R.B. HCG binding and stimulation of testosterone biosynthesis in the human fetal testis. J. Clin. Endocrinol. Metab. 44 (1977) 963-967
67. Hunt J.S., King C.R., and Wood G.W. Evaluation of human chorionic trophoblast cells and placental macrophages as stimulators of maternal lymphocyte proliferation in vitro. J. Reprod. Immunol. 6 (1984) 377-391
68. Hunt J.S., and Hsi B.-L. Evasive strategies of trophoblast cells: Selective expression of membrane antigens. Am. J. Reprod. Immunol. 23 (1990) 57-63
69. Hynes R.O. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69 (1992) 11-25
70. Irving J.A., and Lala P.K. Decidua-derived IGFBP-1 stimulates human intermediate trophoblast migration by binding to the α5/β1 integrin subunits. Placenta 15 (1994) A31
71. Jaameri K.E.U., Koivuniemi A., and Carpen E.O. Occurrence of trophoblasts in the blood of toxemic patients. Gynaecologica 160 (1965) 315-320
72. Jackson M.R., Carney E.W., Lye S.J., and Knox Ritchie J.W. Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta 15 (1994) 341-353
73. Jakeman L.B., Armanini M., Phillips H.S., and Ferrara N. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 133 (1993) 848-859
74. Jones C.T. Endocrine and metabolic interaction between placenta and fetus: Pathways of maternal-fetal communication. In: Redman C.W.G., Sargent I.L., and Starkey F.M. (Eds). The Human Placenta (1993), Blackwell Scientific Publications, London 527-557
75. Jones S.A., and Challis J.R.G. Steroid, corticotrophin-releasing hormone, ACTH, and prostaglandin interaction in the amnion and placenta of early pregnancy in man. J. Endocrinol. 125 (1990) 153-159
76. Jones S.A., and Challis J.R.G. Effects of corticotropin-releasing hormone and adrenocorticotropin on prostaglandin output by human placenta and fetal membranes. Gynecol. Obstet. Invest. 29 (1990) 165-168
77. Keirse M.J.N.C. Eicosanoids in human pregnancy and parturition. In: Mitchell M.D. (Ed). Ei-cosanoids in Reproduction (1990), CRC Press, Boca Raton, FL 199-222
78. Kelly A.M., England P., Lorimer J.D., and Ferguson J.C. An evaluation of human placental lactogen levels in hypertension of pregnancy. Br. J. Obstet. Gynecol. 82 (1975) 272-277
79. Khalfoun B., Degenne D., Crouzat-Reynes G., and Bardes P. Effect of human syncytiotrophoblast plasma membrane-soluble extracts on in vitro mitogen-induced lymphocyte proliferation. A possible inhibition mechanism involving the transferrin receptor. J. Immunol. 137 (1986) 1187-1193
80. Kido I. The human placenta is a manufacturing plant of the so-called anterior lobe pituitary hormones (experimental investigations). [Die menschliche Placenta als produktionsstatte des sogenannten Hypophysonvorderlappenhormons (ex-perimentelle Untersuchungen)]. Zentralblattfur Gynakologie 61 (1937) 1551-1555
81. King R.G. Endothelins and the placenta. In: Rice G.E., and Brennecke S.P. (Eds). Molecular Aspects of Placental and Fetal Membrane Autacoids (1993), CRC Press, Boca Raton, FL 251-261
82. Kitamura K., Kanagawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., and Eto T. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192 (1993) 553-560
83. Kitamura K., Sakata J., Kanagawa K., Kojima M., Matsuo H., and Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem. Biophys. Res. Commun. 194 (1993) 720-725
84. Korhonen M., Ylanne J., Laitinen L., Cooper H.M., Quaranta V., and Virtanen I. Distribution of the α1-α6 integrin subunits in human developing and term placenta. Lab. Invest. 65 (1991) 347-356
85. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., and DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248 (1990) 220-223
86. Kozuka M., Ito T., Hirose S., Takahashi K., and Hagiwara H. Endothelin induces two types of contractions of rat uterus: Phasic contractions by way of voltage-dependent calcium channels and developing contractions through a second type of calcium channels. Biochem. Biophys. Res. Commun. 159 (1989) 317-323
87. Kurman R.J., Main C.S., and Chen H.-C. Intermediate trophoblast: A distinctive form of trophoblast with specific morphological, biochemical and functional features. Placenta 5 (1984) 349-369
88. Laatikainen T., Virtanen T., Kaaja R., and Salminen-Lappalainen K. Corticotropin-releasing hormone in maternal and cord plasma in pre-eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 39 (1991) 19-24
89. Lala P.K., and Graham C.H. Mechanisms of trophoblast invasiveness and their control: The role of proteases and protease inhibitors. Cancer Metastasis Rev. 9 (1990) 369-379
90. Le S.Q., Wasserstrum N., Mombouli J.V., and Vanhoutte P.M. Contractile effect of endothelin in human placental veins: Role of endothelium prostaglandins and thromboxane. Am. J. Obstet. Gynecol. 169 (1993) 919-924
91. Lea R.G., and Clark D.A. Macrophages and migratory cells in endometrium relevant to implantation. Baill. Clin. Obstet. Gynecol. 5 (1991) 25-59
92. R.G. Lea, C.B. Harley, & D.A. Clark (1990). The detection of RNA for TGFβ2 in post-implantation decidual tissue correlates with the detection of a pregnancy associated suppressor. Eur. Fed. Immunol. Soc, 10th meeting, British Society for Immunology, Edinburgh.
93. Lea R.G., Flanders K.C., Harley C.B., Manuel J., Banwatt D., and Clark D.A. Release of a transforming growth factor (TGF)-β2-related suppressor factor from postimplantation murine decidual tissue can be correlated with the detection of a subpopulation of cells containing RNA for TGFβ2. J. Immunol. 148 (1992) 778-787
94. Lessey B.A., Damjanovich L., Coutifaris C., Castelbaum A., Albelda S.M., and Buck C.A. Integrin adhesion molecules in the human endometrium. J. Clin. Invest. 90 (1992) 188-195
95. Librach C.L., Werb Z., Fitzgerald M.L., Chiu K., Corwin N.M., Esteves R.A., Grobelny D., Galardy R., Damsky C.H., and Fisher S.J. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J. Cell Biol. 113 (1991) 437-449
96. Lindhoff C., and Astedt B. Plasminogen activator of urokinase type and its inhibitor of placental type in hypertensive pregnancies and in intrauterine growth retardation: Possible markers of placental function. Am. J. Obstet. Gynecol. 171 (1994) 60-64
97. Liotta L.A. Introductory overview. Cancer Metastasis Rev. 9 (1990) 285-287
98. Liotta L. Immunohistochemical profile of basement membrane proteins and 72 kilodalton type IV collagenase in the implantation site. Lab. Invest. 66 (1992) 572-579
99. Lyons R.M., Keski-Oja J., and Moses H.L. Proteolytic activation of latent transforming growth factor-β from fibroblast conditioned medium. J. Cell Biol. 106 (1988) 1659-1665
100. Malassine A., Cronier L., Mondon F., Mignot T.M., and Ferre F. Localization and production of immunoreactive endothelin-1 in the trophoblast of human placenta. Cell Tissue Res. 271 (1993) 491-497
101. Margioris A.N. Corticotropin-releasing hormone and propiomelanocortin in placenta and fetal membranes. In: Rice G.E., and Brennecke S.P. (Eds). Molecular Aspects of Placental and Fetal Membrane Autacoids (1993), CRC Press, Boca Raton, FL 277-301
102. Martin O., and Arias F. Plasminogen activator production by trophoblast cells in vitro: Effect of steroid hormones and protein synthesis inhibitors. Am. J. Obstet. Gynecol. 142 (1982) 402-409
103. Matsuzaki N., Li Y., Masuhiro K., Jo T., Shimoya K., Taniguchi T., Saji F., and Tanizawa O. Trophoblast-derived transforming growth factor-β 1 suppresses cytokine-induced, but not gonadotropin-releasing hormone-induced, release of human chorionic gonadotropin by normal human trophoblasts. J. Clin. Endocrinol. Metab. 74 (1992) 211-216
104. McMahon L.P., Redman C.W.G., and Firth J.D. Expression of the three endothelin genes and plasma levels of endothelin in pre-eclamptic and normal gestations. Clinical Science 85 (1993) 417-424
105. McWilliams D., and Boime I. Cytological localization of placental lactogen messenger ribonucleic acid in syncytiotrophoblast layers of human placenta. Endocrinology 107 (1980) 761-765
106. Mitchell M.D., Edwin S., and Romero R.J. Prostaglandin biosynthesis by human decidual cells: Effects of inflammatory mediators. Prostaglandins Leukotrienes EFA. 41 (1990) 35-38
107. Mitchell M.D. Endothelins in perinatal biology. Semin. Perinatol. 15 (1991) 79-85
108. Mitchell M.D., Trautman M.S., and Dudley D.J. Cytokine networking in the placenta. Placenta 14 (1993) 249-275
109. Morrish D.W., Bhardwaj D., Dabbagh L.K., Marusyk H., and Siy O. Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta. J. Clin. Endocrinol. Metab. 65 (1987) 1282-1290
110. Morrison J.J., Clark I.M., Powell E.K., Cawston T.E., Hackett G.A., and Smith S.K. Tissue collagenase: Serum levels during pregnancy and parturition. Eur. J. Obstet. Gynecol. 54 (1994) 71-75
111. Myatt L. Placental biosynthesis, metabolism, and transport of eicosanoids. In: Mitchell M.D. (Ed). Eicosanoids in Reproduction (1990), CRC Press, Boca Raton, FL 169-198
112. Myatt L. Current topic: Control of vascular resistance in the human placenta. Placenta 13 (1992) 329-341
113. Myatt L., Brewer A., and Brockman D.E. The action of nitric oxide in the perfused human fetal-placental circulation. Am. J. Obstet. Gynecol. 164 (1991) 687-692
114. Myatt L., Brewer A., Langdon G., and Brockman D.E. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. Am. J. Obstet. Gynecol. 166 (1992) 224-230
115. Myatt L., Brockman D.E., Eis A.L., and Pollack J.S. Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta 14 (1993) 487-495
116. Myatt L., Brockman D.E., Langdon G., and Pollack J.S. Constitutive calcium-dependent isoform of nitric oxide synthase in the human placental villous vascular tree. Placenta 14 (1993) 373-383
117. Oberauer A.M., Linkhart T.A., Mohan S., and Longo L.D. Fibroblast growth factor enhances human chorionic gonadotropin synthesis independent of mitogenic stimulation in Jar choriocarcinoma cells. Endocrinology 123 (1988) 2696-2700
118. Olson D.M., Skinner K., and Challis J.R.G. Prostaglandin output in relation to parturition by cells dispersed from human intrauterine tissues. J. Clin. Endocrinol. Metab. 57 (1983) 694-699
119. Olson D.M., Zakar T., and Mitchell B.F. Prostaglandin synthesis regulation by intrauterine tissues. In: Rice G.E., and Brennecke S.P. (Eds). Molecular Aspects of Placental and Fetal Membrane Autacoids (1993), CRC Press, Boca Raton, FL 55-96
120. Olson D.M., Mijovic J.E., and Sadowsky D.W. Control of human parturition. Semin. Perinatol. 19 (1995) 52-63
121. Osmers R., Rath W., Adelmann-Grill B.C., Fittkow C., Kuloczik M., Szeverenyi M., Tschesche H., and Kuhn W. Origin of cervical collagenase during parturition. Am. J. Obstet. Gynecol. 166 (1992) 1455-1460
122. Pasmanik M., Izhar M., Zolti M., and Shemesh M. Dexamethasone inhibition of prostaglandin production in human term placental cells is protein and ribonucleic acid synthesis dependent. Endocrinology 128 (1991) 2058-2064
123. Pelliniemi L.J., and Dym M. The fetal gonad and sexual differentiation. In: Tulchinsky D., and Ryan K.J. (Eds). Maternal-Fetal Endocrinology (1980), W. B. Saunders Co., Philadelphia 252-280
124. Petraglia F., Sawchenko P.E., Rivier J., and Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing hormone in human placenta. Nature 328 (1987) 717-719
125. Petraglia F., Calza L., Giardino L., Sutton S., Marrama P., Rivier J., Genazzani A.R., and Vale W. Identification of immunoreactive neuropeptide-Y in human placenta: Localization, secretion, and binding sites. Endocrinology 124 (1989) 2016-2022
126. Puistola U., Ronnberg L., Martikainen H., and Turpeenniemi-Hujanen T. The human embryo produces basement membrane collagen (type IV collages-degrading protease activity. Hum. Reprod. 4 (1989) 309-311
127. Purcell D.F.J., McKenzie I.F.C., Lublin D.M., Johnson P.M., Atkinson J.P., Oglesby T.J., and Deacon N.J. The human cell surface glycoproteins HuLy-m5, membrane cofactor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46. Immunology 70 (1990) 155-161
128. Quartero H.W., and Fry C.H. Placental corticotropin-releasing factor may modulate human parturition. Placenta 10 (1989) 439-444
129. Queenan J.T., Kao L.-C., Arboleda C.E., Ulloa-Aguirre A., Golos T.G., Cines D.B., and Strauss J.F. Regulation of urokinase-type plasminogen activator production by cultured human cytotrophoblasts. J. Biol. Chem. 262 (1987) 10903-10906
130. Radetsky P. Stopping premature births before it's too late. Science 266 (1994) 1486-1488
131. Rajabi M., Dean D.D., and Woessner J.F. High levels of serum collagenase in premature labor-a potential biochemical marker. Obstet. Gynecol. 69 (1987) 179-186
132. Rajabi M.R., Dean D.D., and Woessner J.F. Changes in active and latent collagenase in human placenta around the time of parturition. Am. J. Obstet. Gynecol. 163 (1990) 499-505
133. Read M.A., Boura A.L.A., and Walters W.A.W. Vascular actions of purines in the foetal circulation of the human placenta. Br. J. Pharmacol. 110 (1993) 454-460
134. Reith A., Moore N.R., and Bennett B. Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole. Br. J. Obstet. Gynecol. 100 (1993) 370-374
135. Riley S.C., Walton J.C., Herlick J.M., and Challis J.R.G. The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. J. Clin. Endocrinol. Metab. 72 (1991) 1001-1007
136. Romero R., Durum S., Dinarello C.A., Oyarzun E., Hobbins J.C., and Mitchell M.D. Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglandins 37 (1989) 13-22
137. Rose M.P., Elder M.G., and Myatt L. Arachidonic acid metabolism in the human placenta. Troph. Res. 2 (1987) 71-83
138. Rutherford R.A.D., Wharton J., McCarthy A., Gordon L., Sullivan M.H.F., Elder M.G., and Polak J.M. Differential localization of endothelin ETA and ETB binding sites in human placenta. Br. J. Pharmacol. 109 (1993) 544-552
139. Saito S., Kato Y., Maruyama M., and Ichijo M. A study of interferon-β and interleukin-2 production in premature neonates and neonates with intrauterine growth retardation. Am. J. Reprod. Immunol. 27 (1992) 63-68
140. Sappino A.-R., Huarte J., Belin D., and Vassalli J.-D. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos. J. Cell Biol. 109 (1989) 2471-2479
141. Sargent I.L., and Redman C.W.G. Maternal immune responses to the fetus in human pregnancy. In: Stern C.M.M. (Ed). Immunology of Pregnancy and Its Disorders (1989), Kluwer, Dordecht 115-142
142. Sargent I.L., Redman C.W.G., and Starkey P.M. The placenta as a graft. In: Redman C.W.G., Sargent I.L., and Starkey P.M. (Eds). The Human Placenta (1994), Blackwell Scientific Publications, Oxford 334-361
143. Sasagawa M., Yamazaki T., Endo M., Kanazawa K., and Takeuchi S. Immuno-histochemical localization of HLA antigens and placental proteins (αhCG, ßhCG CTP, hPL and SPI) in villous and extravillous trophoblast in normal human pregnancy: A distinctive pathway of differentiation of extravillous trophoblast. Placenta 8 (1987) 515-528
144. Seeburg P.H. The human growth hormone locus: Nucleotide sequence, biology, and evolution. Genomics 4 (1989) 479-497
145. Seron-Ferre M., Lawrence C.C., and Jaffe R.B. Role of hCG in the regulation of the fetal zone of the human fetal adrenal gland. J. Clin. Endocrinol. Metab. 46 (1978) 834-837
146. Shifren J.L., Doldi N., Ferrara N., Mesiano S., and Jaffe R.B. In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: Implications for mode of action. J. Clin. Endocrinol. Metab. 79 (1994) 316-322
147. Shimonovitz S., Hurwitz A., Dushnik M., Anteby E., Geva-Eldar T., and Yagel S. Developmental regulation of the expression of 72 and 92 kd type IV collagenases in human trophoblasts: A possible mechanism for control of trophoblast invasion. Am. J. Obstet. Gynecol. 171 (1994) 832-838
148. Siler-Khodr T.M., and Forman J. The effect of IGF-I on placental prostanoid production. Prostaglandins 46 (1993) 361-370
149. Simon P., Decoster C., Brocas H., Schwers J., and Vassart G. Absence of human chorionic somatomammotropin during pregnancy associated with two types of gene deletion. Hum. Genet. 74 (1986) 235-238
150. Soloff M.S. Uterine receptors for oxytocin: Effects of estrogen. Biochem. Biophys. Res. Commun. 65 (1975) 205-212
151. Spellacy W.N., Buhti W.C., and McCreary S.A. Measurement of human placental lactogen with a simple immunodiffusion kit (Plac Gest). Obstet. Gynecol. 43 (1974) 306-309
152. Spivack M. On the presence or absence of nerves in the umbilical blood vessels of man and guinea pig. Anatom. Rec. 85 (1943) 85-109
153. Starkey P.M. The decidua and factors controlling implantation. In: Redman C.W.G., Sargent I.L., and Starkey P.M. (Eds). The Human Placenta (1994), Blackwell Scientific Publications, Oxford 362-413
154. Starkey P.M., Sargent I.L., and Redman C.W.G. Cell populations in human early pregnancy decidua: Characterization and isolation of large granular lymphocytes by flow cytometry. Immunology 65 (1988) 129-134
155. Strickland S., Reich E., and Sherman M.I. Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endoderm. Cell 9 (1976) 231-240
156. Strickland S., and Richards W.G. Invasion of the trophoblasts. Cell. 71 (1992) 355-357
157. Tabarelli M., Kofler R., and Wick G. Placental hormones: I. Immunofluorescence studies of the localization of chorionic gonadotrophin, placental lactogen and prolactin in human and rat placenta and in the endometrium of pregnant rats. Placenta 4 (1983) 379-388
158. Turpeenniemi-Hujanen T., Ronnberg L., Kauppila A., and Puistola U. Laminin in the human embryo implantation: Analogy to the invasion by malignant cells. Fertil. Steril. 58 (1992) 105-113
159. Testa J.E., and Quigley J.P. Reversal of misfortune: TIMP-2 inhibits tumor cell invasion. JNCI 83 (1991) 740-742
160. Usuki K., Norberg L., Larsson E., Miyazono K., Hellman U., Wernstedt C., Rubin K., and Heldin C.-H. Localization of platelet-derived endothelial cell growth factor in human placenta and purification of an alternatively processed form. Cell Regulation. 1 (1990) 577-596
161. Vaheri A., Stephens R.W., Salonen E.-M., Pollanen J., and Tapiovaara H. Plasminogen activation at the cell surface-matrix interface. Cell Differ. Dev. 32 (1990) 255-262
162. Walker D.W., and MacLean J.R. Absence of adrenergic nerves in human placenta. Nature 229 (1971) 344-345
163. Walters W.A.W. Autacoids affecting vascular tone in the human fetal extracorporeal circulation. Clin. Exp. Pharmacol. Physiol. 19 (1992) 3-8
164. 2 phenomenon? Immunol. Today 14 (1993) 353-356
165. Weir M.R., Li X.W., Gomolka D., Peppier R., O'Bryan-Tear C.G., and Moran M.A. The immunosuppressive properties of enisoprost and a 5-lipoxygenase inhibitor (SC-45662). Transplantation 52 (1991) 1053-1057
166. Werb Z., Tremble P., and Damsky C.H. Regulation of extracellular matrix degradation by cell-extracellular matrix interactions. Cell Differ. Dev. 32 (1990) 299-306
167. Word R.A., Kamm K.E., Stull J.T., and Casey M.L. Endothelin increases cytoplasmic calcium and myosin phosphorylation in human myometrium. Am. J. Obstet. Gynecol. 162 (1990) 1103-1108
168. Yagel S., Geva T.E., Solomon H., Shimonovitz S., Reich R., Finci-Yeheskel Z., Mayer M., and Milwidsky A. High levels of human chorionic gonadotropin retard first trimester trophoblast invasion in vitro by decreasing urokinase plasminogen activator and collagenase activities. J. Clin. Endocrinol. Metab. 77 (1993) 1506-1511
169. Yui J., Garcia-Lloret M., Brown A.J., Berdan R.C., Morrish D.W., Wegmann T.G., and Guilbert L.J. Functional, long-term cultures of human term tro-phoblasts purified by column-elimination of CD9 expressing cells. Placenta 15 (1994) 231-246
170. Zini J.-M., Murray S.C., Graham C.H., Lala P.K., Kariko K., Barnathan E.S., Mazar A., Henkin J., Cines D.B., and McCrae K.R. Characterization of urokinase receptor expression by human placental trophoblasts. Blood 79 (1992) 2917-2929
171. Zhou Y., Damsky C.H., Chiu K., Roberts J.M., and Fisher S.J. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotro-phoblasts. J. Clin. Invest. 91 (1993) 950-960